AH Equity Partners LSV II, L.L.C.

10% owner at Navan, Inc. · on record since Oct 29, 2025
10% owner at Nautilus Biotechnology, Inc. · on record since Jun 4, 2026
10% owner at Camelot Entertainment Group, Inc. · on record since Dec 22, 2021

Insider trading activity of AH Equity Partners LSV II, L.L.C.

No transactions on record for AH Equity Partners LSV II, L.L.C..

Track record of AH Equity Partners LSV II, L.L.C.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of AH Equity Partners LSV II, L.L.C.

Co-insiders of AH Equity Partners LSV II, L.L.C.

Andreessen Horowitz LSV Fund II-B, L.P.Camelot Entertainment Group, Inc. +2
Andreessen Horowitz LSV Fund II, L.P.Camelot Entertainment Group, Inc. +2
Andreessen Horowitz LSV Fund II-Q, L.P.Camelot Entertainment Group, Inc. +2
ANDREESSEN MARC LCamelot Entertainment Group, Inc. +2
HOROWITZ BENJAMIN ACamelot Entertainment Group, Inc. +2
AH Bio Fund II-B, L.P.Camelot Entertainment Group, Inc. +1
AH Bio Fund II, L.P.Camelot Entertainment Group, Inc. +1
AH Equity Partners Bio II, L.L.C.Camelot Entertainment Group, Inc. +1
AH Equity Partners LSV I, L.L.C.Camelot Entertainment Group, Inc. +1
Andreessen Horowitz LSV Fund I-B, L.P.Camelot Entertainment Group, Inc. +1
Andreessen Horowitz LSV Fund I, L.P.Camelot Entertainment Group, Inc. +1
Andreessen Horowitz LSV Fund I-Q, L.P.Camelot Entertainment Group, Inc. +1
Abernethy AmyCamelot Entertainment Group, Inc.
AH 2022 ANNUAL FUND-B, L.P.Navan, Inc.
AH 2022 Annual Fund, L.P.Navan, Inc.
AH 2022 ANNUAL FUND-QC, L.P.Navan, Inc.
AH Bio Fund III-B, L.P.Camelot Entertainment Group, Inc.
AH Bio Fund III, L.P.Camelot Entertainment Group, Inc.
AH Bio Fund III-Q, L.P.Camelot Entertainment Group, Inc.
AH Equity Partners 2022 Annual Fund, L.L.C.Navan, Inc.
AH Equity Partners Bio III, L.L.C.Camelot Entertainment Group, Inc.
AH Equity Partners LSV III, L.L.C.Navan, Inc.
AH Equity Partners V, L.L.C.Navan, Inc.
AH Equity Partners V (Parallel), L.L.C.Navan, Inc.
AH Parallel Fund V-A, L.P.Navan, Inc.
AH Parallel Fund V-B, L.P.Navan, Inc.
AH Parallel Fund V, L.P.Navan, Inc.
AH Parallel Fund V-Q, L.P.Navan, Inc.
Akinsanya KarenNautilus Biotechnology, Inc.
ALTMAN MICHAEL SETHNautilus Biotechnology, Inc.
Andreessen Horowitz Fund V-A, L.P.Navan, Inc.
Andreessen Horowitz Fund V-B, L.P.Navan, Inc.
Andreessen Horowitz Fund V, L.P.Navan, Inc.
Andreessen Horowitz Fund V-Q, L.P.Navan, Inc.
Andreessen Horowitz LSV Fund III-B, L.P.Navan, Inc.
Andreessen Horowitz LSV Fund III, L.P.Navan, Inc.
ATWELL ROBERT PCamelot Entertainment Group, Inc.
BANK ROBERT BNautilus Biotechnology, Inc.
BERNS PAUL LCamelot Entertainment Group, Inc.
Borisy AlexisCamelot Entertainment Group, Inc.
Butte Amy SNavan, Inc.
Casdin EliCamelot Entertainment Group, Inc.
CHU DAVIDNautilus Biotechnology, Inc.
Ciarimboli DinaCamelot Entertainment Group, Inc.
CLF Partners, LPNavan, Inc.
C-LSH III LLCCamelot Entertainment Group, Inc.
CMLS Holdings III LLCCamelot Entertainment Group, Inc.
Cohen Ariel M.Navan, Inc.
Conde JorgeCamelot Entertainment Group, Inc.
Dyal H Kaye IIICamelot Entertainment Group, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →